Status:
COMPLETED
Implementation of a Nutritional Tool During Melphalan Autologous Transplant to Improve Caloric and Protein Intake
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Barnes-Jewish Hospital
Conditions:
Melphalan Autologous Transplant
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this pilot before and after interventional study is to determine if early intervention and provision of menus regarding appropriate diet choices for melphalan autologous transplant pati...
Eligibility Criteria
Inclusion
- Patients undergoing melphalan autologous transplants will be included in this study
- All patients that will be included in this pilot before and after interventional study will be inpatient on floors 5900, 6900 or 8900 of Barnes-Jewish Hospital
- Per hospital protocol, all patients who will receive a melphalan autologous transplant will be admitted and remain inpatient for the duration of the transplant process. There will be no exclusion for dietary restrictions or food allergies as the foodservice provided to patients is room service, all food allergies are noted and suitable alternatives are provided as a standard of service.
- Once a patient has been determined to meet criteria for the study, they will be approached by a member of the research team between day -2 and day 0 of transplant for consent. Patients must consent for the study by day +1 of transplant to be enrolled.
Exclusion
- Patients \<18 years of age
- Pregnant women
- Prisoners
- Patient unable to provide informed consent.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03449927
Start Date
January 1 2018
End Date
February 27 2018
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110